S-Ethylisothiourea Hydrobromide CAS 1071-37-0 Purity > 98.0% Ensitrelvir (S-217622) Intermediate COVID-19

Lus piav qhia luv luv:

Lub npe tshuaj: S-Ethylisothiourea Hydrobromide

CAS: 1071-37-0 Nr

Purity:> 98.0% (HPLC)

Cov tsos mob: Dawb rau Yuav luag Dawb Hmoov rau Crystal

Intermediate of Ensitrelvir (S-217622), COVID-19

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Commercial Supply Ensitrelvir (S-217622) Intermediates:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
Tom ntej: 2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Chemical Properties:

Tshuaj npe	S-Ethylisothiourea Hydrobromide
CAS Nr	1071-37-0 : kuv
CAT Number	Qauv TSIS MUAJ: RF-PI1502
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C3H8N2S · HBr
Molecular Luj	185.08 Nws
Melting Point	79.0 ~ 81.0 ℃
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Dawb rau Yuav luag Dawb Hmoov rau Crystal
Purity	> 98.0%
Poob rau ziab	<0.50%
Ib leeg Impurity	<0.50%
Tag nrho cov impurities	<2.00%
Heavy Metals (raws li Pb)	<20 ppm
Test Standard	Enterprise Standard
Kev siv	Pharmaceutical Intermediates;Intermediate ntawm Ensitrelvir (S-217622)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

FAQ:

Daim ntawv thov:

S-Ethylisothiourea Hydrobromide (CAS: 1071-37-0) tuaj yeem siv los ua cov organic synthesis intermediate thiab tshuaj intermediate.S-Ethylisothiourea Hydrobromide tuaj yeem siv rau hauv kev sib txuas ntawm Ensitrelvir (S-217622).Ensitrelvir (S-217622) is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM).